New immunotherapy trial announced – Brain Tumour Research
|
New immunotherapy trial announced
Brain Tumour Research Details of a new immunotherapy trial for patients with brain tumours have just been announced. The phase two study of the drug ipilimumab, which will be led by Dr Paul Mulholland from the National Hospital for Neurology and Neurosurgery in London, will … |
